Subsequent reactions were common and often more serious than were the initial reactions of children with peanut allergyPDF
ACP J Club. 2001 Jul-Aug;135:35. doi:10.7326/ACPJC-2001-135-1-035
Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000 Dec;137:749-55. [PubMed ID: 11113829]
In young children with peanut allergy diagnosed before 4 years of age, what is the nature and rate of adverse reactions caused by accidental peanut exposure?
Cohort study with a median of 5.9 years (range 1.4 to 22.4 y) of follow-up.
Boulder, Colorado, USA.
102 children with clinical peanut hypersensitivity diagnosed before their fourth birthday. Children were included if they had a convincing history of clinical peanut hypersensitivity; a positive, double-blind, placebo controlled food-challenge response to peanuts, or both; and a positive skin-prick test response to peanuts. Data for 83 children (81%) (median age 2.4 y, 69% boys) were available for the analysis.
Assessment of prognostic factors
Initial assessment records: severity of symptoms (non-life-threatening or potentially life threatening); organ system involvement (skin, respiratory, gastrointestinal, or other); and serum peanut-specific immunoglobulin E (IgE) levels (in 51 of 83 [61%] children).
Main outcome measures
Subsequent adverse reactions after a first peanut exposure were assessed at least yearly.
50 children (60%) had a total of 115 adverse reactions caused by accidental peanut exposure during follow-up (mean 0.33 adverse reactions/y). During their first reaction, 12 children (14%) had skin symptoms alone after only skin contact with peanuts; 26 (31%) had skin symptoms alone after eating peanuts; and 45 (54%) had respiratory symptoms, gastrointestinal symptoms, skin symptoms, or all 3.
61 children (73%) had non-life-threatening first reactions to accidental peanut exposure, and 22 (27%) had potentially life-threatening first reactions. Of the 61 children with non-life-threatening first reactions, 43 had a subsequent reaction, with 19 (44%) being potentially life threatening. Of the 22 children with potentially life-threatening first reactions, 17 had a subsequent reaction, with 12 (71%) being potentially life threatening. Overall, of the 60 children (72%) with ≥ 1 subsequent reaction, 31 (52%) had ≥ 1 potentially life-threatening subsequent reaction.
Of the 51 children who had their serum peanut-specific IgE levels measured, those who had subsequent skin symptoms alone (n = 11) had a lower median serum peanut-specific IgE level than did those who had subsequent respiratory symptoms or gastrointestinal symptoms, or both (n = 40) (1.25 vs 11.65 kUA/L, P = 0.004). However, no threshold level for serum peanut-specific IgE existed below which only skin symptoms occurred.
Most young children with clinical peanut hypersensitivity continued to have adverse reactions to accidental peanut exposure; however, symptoms experienced during a subsequent adverse peanut reaction were not easily predictable either from symptoms experienced during a first reaction or from immunoglobulin E levels.
Source of funding: No external funding.
For correspondence: Dr S.A. Bock, Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, Room J211, Denver, CO 80206, USA. Fax 303-443-5030.
The incidence of peanut allergy, which commonly occurs in the United States and in the United Kingdom, appears to be increasing, possibly because of earlier exposure to peanut antigen in the diet. Reactions can be life threatening (e.g., laryngeal edema or asphyxia), and sensitivity is less likely to be lost with advancing age than is the case with milk or egg allergy. Unfortunately, peanut protein avoidance, the key to management, is problematic given the widespread inclusion of peanut in different foods. Patients and their caregivers, therefore, are often given an injection device for self-administration of epinephrine (adrenaline) for emergency use.
This study included children with well-defined reactions to peanut in an attempt to define the frequency and type of adverse event precipitated by subsequent accidental exposure. Adverse reactions were relatively common, which emphasizes the difficulty of antigen avoidance. Among those children who had mild reactions on first exposure, almost half had life-threatening symptoms on later accidental exposure. Those children who had only skin symptoms during first and subsequent peanut exposure had lower concentrations of serum peanut-specific IgE than did those who had respiratory or gastrointestinal symptoms. The overlap between groups, however, meant that IgE measurement could not accurately predict later reaction. Low IgE concentrations were found in 4 patients who subsequently lost hypersensitivity to peanut, an observation that may serve as a guide to identifying those children who should later have formal challenges done.
This study shows that, despite dietary counseling, accidental peanut exposure is common. Furthermore, initial mild reactions in some children do not ensure freedom from more severe symptoms provoked by subsequent accidental exposure. Therefore, extending the use of self-administered adrenaline devices to these patients rather than limiting their prescription to children with initial life-threatening symptoms might be necessary. Clinicians, however, should consider the findings by Sicherer and colleagues (1) that many doctors are unfamiliar with the practicalities of the adrenaline devices they prescribe, and as a result, they frequently fail to effectively teach families and children how to administer this potentially life-saving treatment.
John Puntis, BM, DM
General Infirmary at Leeds
Leeds, England, UK